Advanced Biomedical Technology Inc. (ABT Inc.) was co-founded by a team of material scientists and engineers with more than 10-year experiences in medical-related industry.
In the first quarter of 2018, the first medical-grade product line of biodegradable-polymeric filament for additive manufacturing, MeDFila®, was launched. The superior biocompatibility and adjustable biodegradability of MeDFila® marked a new era of innovation and development of medical devices via additive manufacturing. Meanwhile, a proprietary medical implant manufacturing system was also established to offer an one-stop service on clients’ request.
To get the latest update, follow us on Linkedin ABT Inc. page.
Start-up founded with 4 people and admitted into Biomedical Science Park accelerator in Hsinchu.
1st Proprietary Biomaterial Pilot Plant
Established a biomaterial research lab, proprietary biomedical material pilot plant, and medical-grade printing system.
Admitted into Hsinchu Science Park, capital injected with 1 million USD.
Collaborated on Ph.D. talent incubate project with National Taiwan Applied Research Laboratories.
Established a new headquarter of 3D printing plant at Hsinchu Science Park.
Awarded Taiwan Government Grant
Awarded Taiwan Government Grant (2018 Intra-industry Integration Biomedical Leaps Forward Program)
Officially launched first medical-grade biodegradable 3D printing filament. The brand name is MeDFila®
Formnext 2018 in Frankfurt
Taiwan Healthcare Expo
MeDFila® PCL Series MAF Ready
Advanced Biomedical Technology awarded Taiwan Government Grant
Advanced Biomedical Technology Inc. has received two grants from the Ministry of Science and Technology (MOST) this year. “2019 Biomedical Leap Projects..Read More
(Coming Soon!) BioAsia Show 2019
Advanced Biomedical Technology Inc. will exhibit at BioAsia 2019. The booth No. N114. Welcome to visit us!